OSIRIS THERAPEUTICS, INC. 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Aug 20, 2013
Insider Transaction Report
Form 4
Neumayer Matthew Paul
Principal Accounting Officer
Transactions
- Exercise/Conversion
Incentive stock options, right to buy
2013-08-20$7.74/sh−3,000$23,220→ 14,500 totalExercise: $7.74From: 2012-03-12Exp: 2020-03-12→ Common Stock (3,000 underlying) - Exercise/Conversion
Incentive stock option, right to buy
2013-08-20$16.75/sh−4,000$67,000→ 10,500 totalExercise: $16.75From: 2012-10-20Exp: 2018-10-20→ Common stock (4,000 underlying) - Exercise/Conversion
Incentive stock option, right to buy
2013-08-20$5.08/sh−875$4,445→ 9,625 totalExercise: $5.08From: 2013-03-23Exp: 2022-03-23→ Common stock (875 underlying) - Sale
Common STock
2013-08-20$19.75/sh−11,375$224,656→ 0 total - Exercise/Conversion
Incentive Stock Options, right to buy
2013-08-20$6.46/sh−1,500$9,690→ 17,500 totalExercise: $6.46From: 2012-05-27Exp: 2020-05-27→ Common stock (1,500 underlying) - Exercise/Conversion
Common Stock
2013-08-20$6.46/sh+1,500$9,690→ 3,500 total - Exercise/Conversion
Common Stock
2013-08-20$5.08/sh+875$4,445→ 11,375 total - Exercise/Conversion
Incentive Stock Options, right to buy
2013-08-20$7.13/sh−2,000$14,260→ 19,000 totalExercise: $7.13From: 2013-02-14Exp: 2021-02-14→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2013-08-20$7.13/sh+2,000$14,260→ 2,000 total - Exercise/Conversion
Common Stock
2013-08-20$7.74/sh+3,000$23,220→ 6,500 total - Exercise/Conversion
Common Stock
2013-08-20$16.75/sh+4,000$67,000→ 10,500 total
Footnotes (1)
- [F1]Represents incentive stock options to purchase common stock with the stated expiration date